MANAMA: Investcorp announced that Urs Rohner has been appointed as a member of its international advisory board from the first of this month.
Mr Rohner is an international banker and businessman with more than 25 years of experience in international financial markets, serving at the highest levels of corporate decision making.
He was most recently chairman of the board at Credit Suisse Group, where he also served as chair of the governance and nominations committee and the Credit Suisse Research Institute, from 2011 until his departure in 2021.
Mr Rohner also sits on the board of directors of GlaxoSmithKline.
Commenting on the appointment, Investcorp executive chairman Mohammed Alardhi said: “We are very pleased to welcome Urs Rohner to our international advisory board. Urs brings a wealth of knowledge and experience accumulated throughout a distinguished career at the highest levels of international finance. As we continue on Investcorp’s growth journey, and remain focused on achieving our ambitions, we are continually searching for the best and most strategic advisors from a diverse range of relevant practice areas to support us.”
Mr Rohner added; “Investcorp has established itself as a leader in the global alternatives investment sector. I look forward to collaborating with the board to help realise the full potential of the growth strategy it has embarked upon.”
The Bahrain-based alternative investment manager’s international advisory board is chaired by Mr Alardhi, and consists of: Professor Heizo Takenaka, Dr Ute Faber, Frances Townsend, Dr Wolfgang Schussel, Deepak Parekh, Ana Palacio, Professor Frederick Si Hang, Dr Wolfgang Ischinger, Sir Michael Fallon, Dr Mohamed El Erian and Dr Ann-Kristin Achleitner.
© Copyright 2020 www.gdnonline.com
Copyright 2021 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).
